FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy.

Saved in:
Bibliographic Details
Title: FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy.
Authors: Davern, Maria1 (AUTHOR), Donlon, Noel E.1 (AUTHOR), Sheppard, Andrew S.1 (AUTHOR), Majcher, Klaudia D.2 (AUTHOR), Connell, Fiona O'2 (AUTHOR), Heeran, Aisling B.2 (AUTHOR), Grant, Malika1 (AUTHOR), Farrell, Robert A.2 (AUTHOR), Hayes, Conall2 (AUTHOR), Bracken-Clarke, Dara1 (AUTHOR), Conroy, Melissa J.1 (AUTHOR), Foley, Emma2 (AUTHOR), Toole, Dermot O'2 (AUTHOR), Bhardwaj, Anshul2 (AUTHOR), Ravi, Narayanasamy2 (AUTHOR), Reynolds, John V.2 (AUTHOR), Maher, Stephen G.3 (AUTHOR), Sullivan, Jacintha O'2 (AUTHOR), Lysaght, Joanne1 (AUTHOR) jlysaght@tcd.ie
Source: Journal of Cancer Research & Clinical Oncology. Jul2023, Vol. 149 Issue 7, p3753-3774. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01715216
DOI:10.1007/s00432-022-04283-9